These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5577492)

  • 1. Enhancement of the coronary dilator effect of intravenous and intracoronary administered adenosine by hexobendine in dogs.
    Raberger G; Kraupp O
    Eur J Pharmacol; 1971; 13(3):312-9. PubMed ID: 5577492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs].
    Raberger G; Weissel M; Kraupp O
    Arzneimittelforschung; 1973 Jun; 23(6):764-8. PubMed ID: 4740758
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enhancement of the coronary dilator action of i.v. and i.c. administered adenosine following intraduodenal provision of hexobendine in dogs].
    Raberger G; Kraupp O
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):430-1. PubMed ID: 4254341
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of coronary vasodilator action of adenosine triphosphate by dipyridamole.
    Afonso S; O'Brien GS
    Circ Res; 1967 Apr; 20(4):403-8. PubMed ID: 6025404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 9. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of Hexobendine on regional cerebral blood flow in stroke patients.
    McHenry LC; Jaffe ME; Kawamura J; Goldberg HI
    Neurology; 1970 Apr; 20(4):375. PubMed ID: 5534978
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
    Buyniski JP; Losada M; Bierwagen ME; Gardier RW
    J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of coronary vasodilating action of adenosine by dilazep and dipyridamole in the dog.
    Sano N
    Jpn J Pharmacol; 1974 Jun; 24(3):471-8. PubMed ID: 4449152
    [No Abstract]   [Full Text] [Related]  

  • 13. Species differences in action and elimination of adenosine after dipyridamole and hexobendine.
    Kolassa N; Pfleger K; Träm M
    Eur J Pharmacol; 1971; 13(3):320-5. PubMed ID: 5577493
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation of the coronary vasodilator effect of norepinephrine by 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine (dipyridamole).
    Hashimoto K; Sano N
    Tohoku J Exp Med; 1968 Oct; 96(2):207-8. PubMed ID: 5708523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
    Osugi S
    Jpn Circ J; 1971 Feb; 35(2):268-80. PubMed ID: 5109720
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1920-6. PubMed ID: 4480355
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of coronary vasodilating action of ATP and adenosine by lidoflazine.
    Afonso S; O'Brien GS; Crumpton CW
    Circ Res; 1968 Jan; 22(1):43-8. PubMed ID: 5635208
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of a trimethoxybenzoic acid derivative on the coronary circulation in the human].
    Behrenbeck DW; Wagner J; Hellwig H; Grenzmann M; Hilger HH
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():287-92. PubMed ID: 5736278
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of coronary vasodilator action of adenosne by 1,4-Bis-(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine (Dilazep I.N.N.).
    Sano N; Katsuki S; Kawada M
    Arzneimittelforschung; 1972 Oct; 22(10):1655-8. PubMed ID: 4677053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.